Activation of cannabinoid receptor 2 (CB2) decreases inflammatory responses and the production of proinflammatory cytokines and is protective in mouse models of neurodegenerative diseases, including multiple sclerosis, ALS, and Parkinson's disease. The gene discussed is CNR2; the disease is amyotrophic lateral sclerosis.